F. Frankenne

发表

Serum Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in the Human Fetus. Relationships with Growth in Normal Subjects and in Subjects with Intrauterine Growth Retardation

M. Binoux, F. Daffos, F. Forestier, 1991, Pediatric Research.

Poster presentations, P795-P836, T1-T21, TP1-TP49

K., R., G. Slegers, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

MTI-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression

L. Devy, J. Foidart, C. Munaut, 2002 .

MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression

L. Devy, J. Foidart, A. Noël, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Comparison of the quantitative performances and measurement uncertainty estimates obtained during method validation versus routine applications of a novel hydrophilic interaction chromatography method for the determination of cidofovir in human plasma.

C. De Bleye, P. Hubert, E. Rozet, 2012, Journal of pharmaceutical and biomedical analysis.

Synthesis, radiosynthesis, in vitro and preliminary in vivo evaluation of biphenyl carboxylic and hydroxamic matrix metalloproteinase (MMP) inhibitors as potential tumor imaging agents.

A. Noël, G. Slegers, A. Heremans, 2005, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

New radioiodinated carboxylic and hydroxamic matrix metalloproteinase inhibitor tracers as potential tumor imaging agents.

J. Foidart, G. Slegers, F. Dumont, 2004, Nuclear medicine and biology.

Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies.

A. Caufriez, G. Hennen, F. Frankenne, 1993, The American journal of physiology.

Placental Growth Hormone Levels in Normal Pregnancy and in Pregnancies with Intrauterine Growth Retardation

G. Hennen, D. Evain-Brion, F. Frankenne, 1993, Pediatric Research.

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

J. Foidart, C. Munaut, D. Cabrol, 2003, The Journal of clinical endocrinology and metabolism.

Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.

J. Foidart, A. Noël, H. Krell, 2000, Experimental cell research.

Cadmium, Zinc and Copper Accumulation in Limpets (Patella vulgata) from the Bristol Channel with Special Reference to Metallothioneins

J. Bouquegneau, F. Frankenne, F. Noël-Lambot, 1980 .

Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.

J. Foidart, C. Munaut, S. Labied, 2007, Human reproduction.

Impact of a new levonorgestrel intrauterine system, Levosert®, on heavy menstrual bleeding: results of a one-year randomised controlled trial

J. Foidart, F. Frankenne, F. Nollevaux, 2014, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Mixed origin of neovascularization of human endometrial grafts in immunodeficient mouse models.

J. Foidart, E. Marbaix, C. Galant, 2009, Human reproduction.

The IGF system in in-vitro human decidualization.

J. Foidart, C. Munaut, F. Frankenne, 2009, Molecular human reproduction.

Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium

J. Foidart, E. Marbaix, S. Labied, 2008, Human reproduction.

Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium

J. Foidart, A. Noël, C. Munaut, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

High production of SPARC/osteonectin/BM-40 in mouse metastatic B16 melanoma cell lines

J. Foidart, A. Noël, Y. Nagashima, 2009, Pathology Oncology Research.

Matrix metalloproteinases and TIMP‐1 production by peripheral blood granulocytes from COPD patients and asthmatics

J. Foidart, A. Noël, C. Munaut, 2001, Allergy.

Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors.

J. Foidart, A. Noël, C. Munaut, 2002, Experimental cell research.

The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant.

M. Scippo, F. Gomez, G. Hennen, 1988, The Journal of clinical endocrinology and metabolism.

Identification of placental human growth hormone as the growth hormone-V gene expression product.

J. van Beeumen, M. Scippo, G. Hennen, 1990, The Journal of clinical endocrinology and metabolism.

Increase in epidermal growth factor receptor and its mRNA levels by parathyroid hormone (1‐34) and parathyroid hormone‐related protein (1‐34) during differentiation of human trophoblast cells in culture

M. Scippo, D. Evain-Brion, F. Frankenne, 1993, Journal of cellular biochemistry.

Isolation and characterization of metallothioneins from cadmium-loaded mussel Mytilus edulis

F. Frankenne, F. Noël-Lambot, A. Distèche, 1980 .

Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.

J. Foidart, C. Munaut, S. Blacher, 2008, Human reproduction.

MMP-2- and MMP-9-Linked Gelatinolytic Activity in the Sputum from Patients with Asthma and Chronic Obstructive Pulmonary Disease

J. Foidart, A. Noël, C. Munaut, 2000, International Archives of Allergy and Immunology.

Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor

J. Foidart, A. Noël, H. Angliker, 1998, FEBS letters.

Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents.

J. Foidart, B. Cornelissen, G. Slegers, 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Growth hormone secretion during termination of pregnancy

G. Hennen, F. Frankenne, S. Edén, 1988, Acta obstetricia et gynecologica Scandinavica.

Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1

J. Rakic, V. Lambert, L. Devy, 1999 .

Effect of oestrogen status on serum levels of growth hormone‐binding protein and insulin‐like growth factor‐I in non‐pregnant and pregnant women

A. Igout, G. Massa, F. Frankenne, 1993, Clinical endocrinology.

Performance evaluation of microbead and ELISA assays for follicular G-CSF: a non-invasive biomarker of oocyte developmental competence for embryo implantation.

J. Foidart, C. Munaut, V. Sérazin, 2010, Journal of reproductive immunology.

Cloning and nucleotide sequence of placental hGH-V cDNA.

M. Scippo, G. Hennen, A. Igout, 1988, Archives internationales de physiologie et de biochimie.

317-324 Autoimmunity

M. Moutschen, V. Geenen, F. Goffin, 2003 .

AUTOIMMUNITY AND PREGNANCY: THEORY AND PRACTICE

M. Moutschen, V. Geenen, F. Goffin, 2002, Acta clinica Belgica.

In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker.

J. Foidart, B. Cornelissen, G. Slegers, 2005, Nuclear medicine and biology.

Membrane Type 1 Matrix Metalloproteinase-associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines*

J. Foidart, A. Noël, C. Munaut, 2000, The Journal of Biological Chemistry.

Molecular interactions involving urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1), as new targets for tumour therapy

J. Foidart, A. Noël, C. Munaut, 1999 .

Growth hormone 24‐h serum profiles during pregnancy—lack of pulsatility for the secretion of the placental variant

G. Hennen, F. Frankenne, S. Edén, 1989, British journal of obstetrics and gynaecology.

Regulation of membrane-type 1 matrix metalloproteinase activity by vacuolar H+-ATPases.

J. Foidart, A. Noël, K. Peyrollier, 2003, The Biochemical journal.

Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents.

A. Noël, G. Slegers, C. Van de Wiele, 2005, Cancer biotherapy & radiopharmaceuticals.

Synthesis, quality control and in vivo evaluation of [I-123] rhTIMP-2, a potential tumour-imaging agent

J. Foidart, G. Slegers, A. Lejeune, 2005 .

Membrane type 1 matrix metalloproteinase detection in tumors, using the iodinated endogenous [123I]-tissue inhibitor 2 of metalloproteinases as imaging agent.

J. Foidart, L. Vervoort, C. Van de Wiele, 2010, Cancer biotherapy & radiopharmaceuticals.

Monoclonal antibody to growth hormone the discovery of a new variant, human placental growth hormone

A. Beckers, F. Gomez, G. Hennen, 1985 .

The amino acid sequence of the pike (Esox lucius) parvalbumin III

C. Gerday, F. Frankenne, L. Joassin, 1973 .

Acidic Extracellular pH Induces Matrix Metalloproteinase-9 Expression in Mouse Metastatic Melanoma Cells through the Phospholipase D-Mitogen-activated Protein Kinase Signaling*

J. Foidart, A. Noël, M. Baba, 2005, Journal of Biological Chemistry.

Modeling lymphangiogenesis in a 3 D-culture system

P. Carmeliet, J. Foidart, A. Noël, 2009 .

Effects of Tibolone on Sulfatase Pathway of Estrogens Metabolism and on Growth of MCF-7 Human Breast Tumors Implanted in Ovariectomized Nude Mice

J. Foidart, A. Noël, M. Putman, 2006, Gynecologic and Obstetric Investigation.

A human placental GH: increasing levels during second half of pregnancy with pituitary GH suppression as revealed by monoclonal antibody radioimmunoassays.

F. Gomez, G. Hennen, F. Frankenne, 1985, International journal of fertility.

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent

J. Foidart, B. Cornelissen, G. Slegers, 2004 .

Evidence for the expression of growth hormone receptors in human placenta.

M. Scippo, G. Hennen, A. Igout, 1992, Biochemical and biophysical research communications.

New functions of stromal proteases and their inhibitors in tumor progression.

L. Devy, J. Foidart, A. Noël, 2001, Surgical oncology clinics of North America.

Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH.

F. de Zegher, A. Beckers, G. Hennen, 1990, The Journal of clinical endocrinology and metabolism.

Effect of Matrigel on Human Extravillous Trophoblasts Differentiation: Modulation of Protease Pattern Gene Expression1

J. Foidart, C. Munaut, M. Vidaud, 2002, Biology of reproduction.

Human placental growth hormone.

D. Luton, M. Scippo, J. Guibourdenche, 1992, American journal of obstetrics and gynecology.

Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor

L. Devy, J. Foidart, A. Noël, 2004, Clinical Cancer Research.

6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis.

J. Foidart, A. Noël, S. Blacher, 2008, European journal of medicinal chemistry.

1H‐NMR studies of the histidine residues of human choriogonadotropin and its α‐ and β‐subunits

G. Roberts, F. Frankenne, B. Birdsall, 1983 .

Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.

J. Foidart, A. Beckers, G. Hennen, 1990, The Journal of clinical endocrinology and metabolism.

Immunocytochemical localization of the human growth hormone variant in the human placenta.

G. Hennen, F. Frankenne, G. Bryant-Greenwood, 1989, The Journal of clinical endocrinology and metabolism.

Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta

M. Scippo, E. Hooghe-Peters, B. Velkeniers, 1993, Molecular and Cellular Endocrinology.

Regulation of growth hormone secretion in human trophoblastic cells in culture.

M. Scippo, G. Hennen, D. Evain-Brion, 1990, Hormone research.

Expression of the growth hormone variant gene in human placenta.

J. Martial, M. Scippo, F. Rentier-Delrue, 1987, The Journal of clinical endocrinology and metabolism.

CURRENT DEVELOPMENT Human placental growth hormone

D. Luton, J. Guibourdenche, D. Evain-Brion, 1997 .

Transient reduction of placental angiogenesis in PAI-1-deficient mice.

P. Carmeliet, J. Foidart, A. Noël, 2011, Physiological genomics.

NEW CHORIONIC GH-LIKE ANTIGEN REVEALED BY MONOCLONAL ANTIBODY RADIOIMMUNOASSAYS

F. Gomez, G. Hennen, F. Frankenne, 1985, The Lancet.

Presence of oestrogen receptor type β in human retina

J. Rakic, V. Lambert, J. Foidart, 2001, The British journal of ophthalmology.

Placental growth hormone variant: assay and clinical aspects

G. Hennen, A. Igout, D. Evain-Brion, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Purification and biochemical characterization of recombinant human placental growth hormone produced in Escherichia coli.

B. Devreese, J. van Beeumen, M. Scippo, 1993, The Biochemical journal.

Modeling lymphangiogenesis in a three-dimensional culture system

P. Carmeliet, J. Foidart, A. Noël, 2008, Nature Methods.

Trophoblast invasion and placentation: molecular mechanisms and regulation.

J. Foidart, A. Noël, C. Munaut, 2005, Chemical immunology and allergy.

Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth.

A. Caufriez, G. Hennen, F. Frankenne, 1994, Hormone research.

[Human placental growth hormone].

M. Scippo, G. Hennen, A. Igout, 1992, Anales espanoles de pediatria.

Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy.

A. Caufriez, F. Cantraine, Y. Englert, 1990, The American journal of physiology.

Evidence of a limited contribution of feto-maternal interactions to trophoblast differentiation along the invasive pathway.

J. Foidart, C. Munaut, F. Goffin, 2003, Tissue antigens.

Adhesion of endometrial cells labeled with 111Indium-tropolonate to peritoneum: a novel in vitro model to study endometriosis.

J. Foidart, A. Noël, F. Goffin, 2003, Fertility and sterility.

Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.

J. Foidart, C. Munaut, E. Marbaix, 2008, Human reproduction.

Role of endocrine status and cell type in adhesion of human endometrial cells to the peritoneum in nude mice.

J. Foidart, A. Noël, F. Goffin, 2002, Fertility and sterility.

Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor.

J. Foidart, Y. Ville, L. Lombardelli, 2008, Human reproduction.

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

J. Rakic, V. Lambert, P. Carmeliet, 2007, The American journal of pathology.

Fetal hypopituitarism: perinatal endocrine and morphological studies in two cases

C. Christophe, C. Heinrichs, F. Frankenne, 1994, Acta paediatrica.

Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions.

J. Foidart, P. Chiap, L. Delattre, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.

L. Devy, J. Foidart, A. Noël, 2001, Cancer research.

Mammary Tumor Growth and Angiogenesis Tissue Inhibitor of Metalloproteinase-2 : Effect on in Vivo Down-Regulation of Vascular Endothelial Growth Factor by Updated

L. Devy, J. Foidart, A. Noël, 2001 .

Expression Pattern of Metalloproteinases and Tissue Inhibitors of Matrix-Metalloproteinases in Cycling Human Endometrium1

J. Foidart, C. Munaut, A. Colige, 2003, Biology of reproduction.

IN CYCLING HUMAN ENDOMETRIUM

J. Foidart, C. Munaut, A. Colige, 2003 .

Monoclonal Antibodies for the Study of Human Growth Hormone Forms and Variants

F. Gomez, G. Hennen, F. Frankenne, 1988 .

Adenohypophysis hormone gene products in 14 pituitary adenomas: analysis by immunohistochemistry and northern blotting.

M. Scippo, A. Beckers, G. Hennen, 1991, Archives internationales de physiologie, de biochimie et de biophysique.

Mammosomatotropes in human pituitary adenomas as revealed by electron microscopic double gold immunostaining method.

A. Beckers, G. Hennen, J. Boniver, 1988, Acta endocrinologica.

Expression of membrane type 1 matrix metalloproteinase (MT1‐MMP) in A2058 melanoma cells is associated with MMP‐2 activation and increased tumor growth and vascularization

J. Foidart, A. Noël, C. Munaut, 2002, International journal of cancer.

Induction of SPARC by VEGF in human vascular endothelial cells.

J. Foidart, A. Noël, Y. Nagashima, 2001, Biochemical and biophysical research communications.

Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma. Role of the Fc‐binding capacity of protein A in the side effects and the tumoricidal response

G. Hennen, W. Bensinger, F. Frankenne, 1986, European journal of clinical investigation.

New biological investigations on 3‐bromophenyl 6‐acetoxymethyl‐2‐oxo‐2H‐1‐benzopyran‐3‐carboxylate as anti‐angiogenic agent

V. Lambert, J. Foidart, A. Noël, 2010 .

Human placental growth hormone: proof of identity with the GH-V gene product by N-terminal microsequence analysis.

M. Scippo, G. Hennen, A. Igout, 1989 .

Subfemtomole enzyme immunoassay for human growth hormone using affinity chromatography and enzyme amplified detection.

F. Gomez, G. Hennen, F. Frankenne, 1990, Analytical biochemistry.

Molecular approach to intrauterine growth retardation: an overview of recent data.

G. Hennen, A. Igout, D. Evain-Brion, 1995, Reproduction, Fertility and Development.

Endothelial metalloprotease-disintegrin protein (ADAM) is implicated in angiogenesis in vitro

Hong Li, J. Soria, C. Soria, 2004, Angiogenesis.

Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases*

J. Foidart, C. Munaut, C. Gilles, 2004, Journal of Biological Chemistry.

Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.

M. L’Hermite-Balériaux, Anandi Martin, G. Hennen, 1995, Growth regulation.

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

J. Rakic, V. Lambert, P. Carmeliet, 2001 .

Controlled release of drugs from multi-component biomaterials.

V. Maquet, C. Jérôme, R. Jerome, 2008, Acta biomaterialia.

Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.

J. Foidart, W. Bode, A. Noel, 2004, Journal of molecular biology.

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

J. Rakic, V. Lambert, P. Carmeliet, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Dual monoclonal antibody immunoassay for free prostate‐specific antigen

R. Wolfert, F. Frankenne, R. Sokoloff, 1996, The Prostate.

Human Endometrial Epithelial Cells Modulate the Activation of Gelatinase A by Stromal Cells

J. Foidart, V. Geenen, F. Goffin, 2002, Gynecologic and Obstetric Investigation.

[Influence of placental protein hormones on maternal physiology].

G. Hennen, F. Frankenne, 1987, Annales d'endocrinologie.

Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation.

P. Hubert, B. Evrard, R. Snoeck, 2018, International journal of clinical pharmacology and therapeutics.